RELAPSED OSTEOSARCOMA
Clinical trials for RELAPSED OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for RELAPSED OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cell army targets childhood cancers in new trial
Disease control Recruiting nowThis early-phase study tests a new treatment for children whose neuroblastoma or osteosarcoma has not responded to standard therapy or has returned. The approach combines specially grown immune cells (gamma delta T cells) from a healthy donor with several chemotherapy drugs and a…
Matched conditions: RELAPSED OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 09:16 UTC
-
New hope for hard-to-treat bone cancer? experimental drug combo enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called tegavivint combined with the chemotherapy gemcitabine in people whose osteosarcoma (a type of bone cancer) has returned or not responded to standard treatments. The main goal is to find the safest dose of tegavivint when given with g…
Matched conditions: RELAPSED OSTEOSARCOMA
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 08:59 UTC